Could a new drug help people with severe asthma breathe easier?

Living with moderate to severe asthma can be challenging, with frequent flare-ups making it hard to breathe and enjoy life. A new study is evaluating a drug called brenipatide to see if it can help adults with this condition. The study will last about 65 weeks and will compare different doses of brenipatide to a placebo, which is a treatment that doesn’t contain an active drug. The main goal is to measure how often asthma flare-ups occur over a year of treatment. With an estimated 531 participants, this research could provide valuable insights into a new option for those struggling to control their asthma. If brenipatide proves effective, it might lead to better control of symptoms and improved quality of life for many people.